Results 1 - 25 from 32 for "cegedim"
-
Cegedim: Romania Medicine Market Grows 13.8% in 2024 To RON34B
02.05.2025
Romanians bought medicines worth RON34 billion (EUR6.86 billion) last year, 13.8% more than in 2023, as prescription drugs in pharmacies totaled RON20.8 billion (up 14.2%) and OTC ones RON8 billion, more
-
Cegedim: Local Producers Accounted For One Third Of Drugs Sold In Romania In H1 2024
09.04.2024
Local production of medicines covered 29% of drug sales in Romania in the first six months of 2024, an analysis by market research company Cegedim shows. more
-
Cegedim: Romania Medicine Market Grows 15.5% in Q1/2024 To RON8.15B
05.08.2024
Medicine sales went up by 15.5% in the first quarter of 2024 from the year-earlier period, to RON8.15 billion, as retail sales rose by 14.4% and hospital consumption increased by 22.5%, in line with a more
-
Cegedim: Romania Medicine Market Grows 16% YoY To RON29.96B In 2023
02.01.2024
Romanians bought medicines worth RON26.8 billion (EUR5.44 billion) in the period April 2022 – March 2023, at wholesale prices, 20% more than in the year-earlier period, in line with a report of more
-
Cegedim: Romania Medicine Market Grows 20% YoY To Nearly RON27B In April 2022-March 2023 Period
05.05.2023
Romanians bought medicines worth RON26.8 billion (EUR5.44 billion) in the period April 2022 – March 2023, at wholesale prices, 20% more than in the year-earlier period, in line with the Cegedim more
-
Cegedim: Romania Medicine Market Grows 21% To RON24B In Oct 2021-Sept 2022 Period
11.17.2022
Romanians bought medicines worth RON24 billion (EUR5 billion) in the period October 2021 – September 2022, at wholesale prices, 21% more than in the year-earlier period, in line with the Cegedim more
-
Cegedim: Romania Medicine Market Grows 22% To RON22.2B In April 2021-March 2022 Period
05.04.2022
Romanians bought medicines worth RON22.2 billion (EUR4.51 billion) in the period April 2021 – March 2022, at wholesale prices, 22.6% more than in the year-earlier period, in line with the Cegedim more
-
Sales of Dermo-Cosmetics up 27% to RON360M in Romania in 2021
02.07.2022
Sales of dermo-cosmetics in pharmacies in Romania increased by 27% to a total of RON360 million (EUR73.2 million) last year and the market was dominated by facial care products, which accounted for more
-
Cegedim: Romania Medicine Market Up 10.6% By Value To RON19B, Up 0.6% By Volume In Past 12 Months
08.04.2021
Romanians used medical drugs worth RON19 billion (EUR3.9 billion), at wholesale prices, in the period July 2020-June 2021, 10.6% more than in the year-earlier period, Cegedim research showed more
-
Dermo-Cosmetics Sales in Romania Down 2.7% in 2020, to RON261.9M
02.17.2021
Romanians bought RON261.9 million (EUR54.1 million) worth of dermo-cosmetics at retail prices in 2020, down 2.7% compared with 2019, a market report by Cegedim Customer showed Wednesday. more
-
Romanian Pharmaceutical Market Grows 1.3% in 2020, to RON18B
02.12.2021
The pharmaceutical market in Romania grew 1.3% in 2020, to RON18 billion (EUR3.7 billion), while medication sales in volume stood 625 million packs, the same as in 2019, Cegedim research showed more
-
Cegedim: Medicine Market Drops 2.1% by Volume, 4% by Value in Past 12 Months
11.16.2020
Romanians bought 614 million packs of medicines in the period October 2019 - September 2020, down 2.1% on the year, Cegedim's Pharma & Hospital Report showed Monday. more
-
Cegedim: Value Of Medical Drugs Released In Pharmacies, Hospitals Up 6.2% To RON18B In April 2019-March 2020
05.04.2020
-
Cegedim: Romania’s Pharmaceutical Market Up 17% Y/Y To RON3.7B In 1Q/2018
06.08.2018
-
Petru Craciun, Cegedim GM: Minimum Price Method Leads To Penury
09.13.2017
-
Cegedim: Romania’s Pharmaceutical Market Reaches RON3.2B In 2Q/2017
08.31.2017
Medicine sales in Romania reached RON13.13 billion between July 2016 and June 2017, up 10% from the year-earlier period, which marks a revival of the profile market, according to a study by market more
-
Cegedim: Romania’s Pharmaceutical Market Up 10% To RON12.9B In 2016
03.03.2017
-
Medicine Sales In Romania Down 4.1% To RON2.83B In 2Q
08.24.2015
Medicine sales in Romania fell 4.1% on the year to RON2.83 billion in the second quarter, considering distribution prices, according to Cegedim's Pharma & Hospital Report. more
-
Romanian Pharmaceutical Market Rose 6.8% In 2014, To EUR2.7B
02.25.2015
Sales of medicines in Romania rose 6.8% last year, to RON12.3 billion (EUR2.76 billion), higher than expected, according to Cegedim, which revised its forecast for 2015 from +1.8% to +3.5%. more
-
Distributors And Retailers Want Demographic Criteria Kept In Pharmacy Market Deregulation
09.29.2014
Romania is not ready for a liberalized pharmaceutical market, which would lead to more drugstores, as it is already among the top countries in Europe by number of drugstores per 1,000 inhabitants, more
-
Romanian Pharmaceutical Market Might Fall By Up To 1.5% In 2014 – Cegedim
09.29.2014
The Romanian pharmaceutical market might fall by up to 1.5% this year, while a return to growth next year would depend on the final version of reimbursed drugs list, Petru Craciun, general manager of more
-
Cegedim: Romanian Pharmaceutical Market Down 4% To EUR669M In 1Q
05.15.2014
Sales of pharmaceutical wholesalers in Romania fell 4% on the year to EUR668.8 million in the first quarter of 2014, below expectations, due to a warmer-than-expected winter, according to Cegedim more
-
Cegedim Sees Romanian Pharmaceutical Market Growing An Average 4.8% in 2014-2018
02.20.2014
The Romanian pharmaceutical market is seen growing 2.7% on the year in 2014, according to Cegedim Romania, which estimates an average growth of 4.8% a year until 2018. more
-
Cegedim: Romanian Pharmaceutical Sales Flat On The Year In 2013, At RON11.7B
02.20.2014
Sales of pharmaceuticals in Romania were flat on the year in 2012, at RON11.75 billion at distribution prices, according to Cegedim. more
-
Cegedim: Romanian Pharma Market’s Growth From EUR1B To EUR2.5B Is Not Abnormal
09.23.2013
Romania’s pharmaceutical market has climbed from EUR1 billion to EUR2.5 billion in less than ten years and its growth is closely related to the evolution of medicine prices, Cegedim head Petru more